ClinicalTrials.gg
CompletedNCT07825610Updated Sep 17, 2026

Lower Crossed Syndrome on Postural Control and Energy Expenditure

An observational study in Lower Crossed Syndrome, sponsored by Alanya Alaaddin Keykubat University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Alanya Alaaddin Keykubat University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
116
Ages
25 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 995 studies in Motor Activity with a site in Turkey — 196 open to participants now, 225 under way, none of them phase 3. Motor Activity · Turkey.

Enrollment
69th of 227
116 · median 70
Started
2024
with 147 others
Observational
227 of 995
36 open now
Registered
968th of 995
by date

Among the 995 studies in Motor Activity with a site in Turkey, this one is the 69th largest by enrollment of the 227 observational ones that give a count, is one of 148 that started in 2024, is one of 227 observational ones, and was the 968th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

196 of the 995 studies in Motor Activity with a site in Turkey are open now. Recruiting first, the newest first:

191 more — sign in →

All 196 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 25 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 995 studies in Motor Activity with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study was to compare postural control, lumbar stabilization, lower extremity proprioception, physical activity level, and energy expenditure level between individuals with Lower Crossed Syndrome (LCS) and healthy controls.

03

Conditions studied

  • Lower Crossed Syndrome

Browse trials for

Keywords

  • Lumbar stabilization
  • Postural control
  • Energy expenditure
  • Physical activity
04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

116 volunteers aged 25-40 years. Participants were divided into an LCS group (n=58) and a healthy control group (n=58).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntary agreement to participate in the study,
  • Being between 25-40 years of age,
  • Not having any orthopedic or neurological problems,
  • Not having received a specific diagnosis that could cause spinal pain (lumbar disc herniation, radiculopathy, spinal tumor, bleeding, abscess, etc.),
  • Not having used any medication for spinal pain in the last 3 months,
  • Not currently receiving physical therapy for lumbar problems.
  • Positive results from at least three of the following tests applied to determine the presence of ACS: modified Thomas test, modified Schober test, lumbar erector spinae shortening test, prone hip extension test, and straight leg raise test.

Exclusion criteria

Exclusion Criteria:

  • Having a specific diagnosis causing spinal pain
  • Having a history of lumbar spine surgery
  • Having used any medication for spinal pain in the last 3 months
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
116 participants (actual)
Patient registry
No

Groups and cohorts

  • 1

    Lower crossed syndrome

  • 2

    Healthy group

06

What researchers measure

Primary outcomes

  1. Postural control

    The Biodex Balance System (Biodex 945-302, Biodex Medical Systems Inc., Shirley, New York, USA) is used for the objective assessment of dynamic postural control. High scores on stability indices indicate greater postural sway and lower postural stability.

    Time frame: Enrollment

  2. Energy Expenditure Level

    Physiological cost (energy expenditure level) is assessed using the Physiological Cost Index during the 6-Minute Walk Test. The index is an indirect measure that allows for the assessment of physiological effort during submaximal activity based on heart rate and walking speed.

    Time frame: Enrollment

Secondary outcomes

  1. Lumbar Stabilization

    Lumbar stabilization is assessed using a Stabilizer Pressure Biofeedback Unit (Chattanooga Group, Hixson, TN, USA). Participants are asked to increase the pressure by 10 mmHg by performing the abdominal drawing-in maneuver and to maintain this pressure for 5 seconds.

    Time frame: Enrollment

  2. Lower Extremity Proprioception

    In the assessment of proprioception, joint position sense measurements are performed using a smartphone-based digital goniometer. After positioning the patients, the knee is placed at flexion angles of 30, 45, and 90 degrees, respectively, and patients are asked to estimate these same positions. These measurements are repeated three times, and the average is recorded.

    Time frame: Enrollment

  3. Physical Activity Level

    Participants' physical activity levels are assessed using the Physical Activity Index (FIT). The FIT score is calculated by multiplying the frequency, intensity, and duration of physical activity. An higher score indicates a higher level of physical activity.

    Time frame: Enrollment

07

Study locations

1 site
  • Alanya Alaaddin Keykubat University
    Antalya, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in May 2026, 19 months.

Of 490 non-industry observational studies under Motor Activity, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's 19 months is below that.

Counting every sponsor, half of 500 studies reached it within 22 months; a quarter within 8 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2026
First posted
Sep 17, 2026
StartActual
Oct 1, 2024
Primary completionActual
May 1, 2026
CompletionActual
Jul 1, 2026
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07825610
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
Ayse Unal (Assoc. Prof, PT.PhD., Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Sep 17, 2026
Start date
Oct 1, 2024
Primary completion
May 1, 2026
Completion
Jul 1, 2026
Last update
Sep 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion